Catheter lock solution with double effectiveness
TauroLock™ is a preventive lock solution suitable for central venous access within hemodialysis and oncology. In order to ensure a catheter with an optimum blood flow, it is important that the lock solution ensures both clotting and infection prevention. Taurolock’s double effectiveness prevents catheter infections and clot formation.
The double effectiveness of TauroLock Urokinase consists of the combination of:
- Taurolidine, prevents bacterial growth and biofilm formation
- 4% citrate, anti-clotting effect
- Urokinase 5000 units per mL, intensive anti-clotting effect
- Besides solving flow problems through the urokinase, TauroLock Urokinase also prevents new formation of clots.
Description: 4% citrate (anti-clotting effect), 1.35% taurolidine (broad antimicrobial activity incl. MRSA and VRE) and 5000 IU/mL urokinase (intensive anticoagulant)
Appearance: 5 ml glass ampoule, vial with lyophilised urokinase injection powder
Package size: Combination of 5 ampoules and 5 vials each per box
Z-index number: 15716309
Item number: 1000460
Manufacturer: Tauropharm
